Sunshine Biopharma (SBFM) Change in Intangibles (2022 - 2026)
Sunshine Biopharma (SBFM) reported Change in Intangibles of $99389.0 for Q1 2026, down 51.41% on a YoY basis from $204527.0 in Q1 2025, and up 142.42% quarter-over-quarter from $40998.0 in Q4 2025.
Sunshine Biopharma (SBFM) Change in Intangibles (2022 - 2026) Analysis & Trends
Sunshine Biopharma has reported Change in Intangibles for 5 years, with the latest figure at $99389.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Intangibles fell 51.41% year-over-year to $99389.0; the trailing twelve-month figure through Mar 2026 stood at $556677.0 (up 605.7% YoY), and the FY2025 full-year result was $661815.0, up 105.37% from the prior year.
- Change in Intangibles for Q1 2026 stood at $99389.0, up from $40998.0 in the prior quarter.
- The five-year high for Change in Intangibles was $686044.0 in Q4 2023, with the low at -$402296.0 in Q2 2024.
- Historically, Change in Intangibles has averaged $135737.5 across 5 years, with a median of $95954.0 in 2024.
- The largest YoY upside for Change in Intangibles was 4185.27% in 2024 against a maximum downside of 150.26% in 2024.
- Sunshine Biopharma's Change in Intangibles stood at $111015.0 in 2022, then jumped by 517.97% to $686044.0 in 2023, then tumbled by 100.7% to -$4830.0 in 2024, then jumped by 948.82% to $40998.0 in 2025, then soared by 142.42% to $99389.0 in 2026.
- The last three Change in Intangibles figures came in at $99389.0 (Q1 2026), $40998.0 (Q4 2025), and $26103.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | 99,389.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,389.00 |
| Mar 31, 2026 | 99,389.00 |
| Dec 31, 2025 | 40,998.00 |
| Dec 31, 2025 | 40,998.00 |
| Sep 30, 2025 | 26,103.00 |
| Sep 30, 2025 | 26,103.00 |
| Jun 30, 2025 | 390,187.00 |
| Jun 30, 2025 | 390,187.00 |
| Mar 31, 2025 | 204,527.00 |
| Mar 31, 2025 | 204,527.00 |
| Dec 31, 2024 | -4,830.00 |
| Dec 31, 2024 | -4,830.00 |
| Sep 30, 2024 | 92,519.00 |
| Sep 30, 2024 | 92,519.00 |
| Jun 30, 2024 | -402,296.00 |
| Jun 30, 2024 | -402,296.00 |
| Mar 31, 2024 | 636,865.00 |
| Mar 31, 2024 | 636,865.00 |
| Dec 31, 2023 | 686,044.00 |
| Dec 31, 2023 | 686,044.00 |